gms | German Medical Science

Über diesen Kongress

This year, the German Agency for Health Technology Assessment at the German Institute of Medical Documentation and Information (DAHTA@DIMDI) looks back at five years of active HTA work. Five years in which HTA has prospered from a special term used by experts to an internationally discussed concept, which in many cases found its way in legislation already. Enough reasons to examine the knowledge, value and prospects of HTA together with HTA experts from all over the world at the meanwhile sixth German HTA symposium.

With "Biomedical Sciences" a focus has been chosen which addresses all aspects of the HTA concept by its political explosiveness and scientific development. Not only genetic therapies or diagnostic developments may raise many questions concerning efficacy, safety, appropriateness and effectiveness; ethical and legal implications are of great importance here as well.

We want to learn about the experiences and procedures of international HTA organisations and to discuss future measures and challenges. Top-class representatives of European HTA institutions, of HTA networks and of the international association HTAi will present their know-how. They are accompanied by participants from politics and science, as well as from international organisations of the health care system, e.g. the OECD.

Traditionally, this year's HTA symposium programme is dedicated to the exchange between HTA users and HTA developers. Accordingly, the symposium will be followed by the module for education and training; this year it concerns the evaluation of trials and the use of international information sources.

Information about the speakers (in alphabetical order)

	Helmut Brand Institute for Public Health NRW
	Helena Dahlgren, Oslo/Norway Vice Director, Swedish Council on Technology Assessment in Health Care (SBU)
	Hans-Peter Dauben, Cologne/Germany Head of Department Medical Transactions, International Affairs, German Institute for Medical Documentation and Information (DIMDI)
	Isabelle Durand-Zaleski, Paris/France Director of the department "Bonnes pratiques et prise du charge", Haute Autorité de Santé (HAS)
	Robert Francke, Bremen/Germany Institut für Gesundheits und Medizinrecht, Universität Bremen, Fachbereich Rechts- wissenschaft, Universität Bremen
	Malene Fabricius Jensen, Copenhagen/Denmark Head of library services at Danish Center for Evaluation and Health Technology Assessment (DACEHTA), National Board of Health, Health Information Services
	John Gabbay, Southampton/Great Britain Professor Emeritus, Wessex Institute of Health, Research and Development, University of Southampton, Former Director of the National Coordinating Center for HTA (NCCHTA), Former Vice President INAHTA, Director HTA
	Iain Gillespie, Paris/France Head of Biotechnology Division, Organisation for Economic Co-operation and Development (OECD)
	Alicia Granados, Copenhagen/Denmark Director of the Health Evidence Network (HEN), Worldhealthorganisation (WHO)
	Niels Wuergeler Hansen, Copenhagen/Denmark Senior Scientist, Danish Center for Evaluation and Health Technology Assessment (DACEHTA)
	Finn Børlum Kristensen, Copenhagen/Denmark Director of the President of the International Network of Agencies of HTA (INAHTA), Head of the EU Project European Network for HTA (EuNetHTA)
	Krysztof Landa, Krakov/Poland Director of the Polish HTA agency CEESTAHC
	Berit Mørland, Oslo/Norway President of the Health Technology Assessment International (HTAi), Vice Director of the Norwegian Knowledge Centre for the Health Service (NKH)
	Alric Rüther, Cologne/Germany Head of the German Agency for HTA at DIMDI
	Stefan Sauerland, Cologne/Germany Biochemical and experimental department, medical faculty at the University of Cologne
	Claudia Wild, Vienna/ Austria Manager of the unit for Health Technology Assessment of the Institute of Technology Assessment of the Austrian Academy of Sciences